New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease

Abstract

Pathology and Cell Biology of Hodgkin's Disease.- Pathology of Hodgkin's Disease: Anything New?.- Immunology of Hodgkin and Reed-Sternberg Cells.- DNA Gene Rearrangement Studies in Hodgkin's Disease and Related Lymphomas: A Contribution to Their Cellular Origin..- Genetics of Hodgkin's Lymphoma.- Hodgkin's Disease Derived Cell Lines.- Biology of Hodgkin Cell Lines.- Phenotypic and Genotypic Analysis of Two Cell Lines Derived from Hodgkin's Disease Tissue Biopsies.- The Typical Reed-Sternberg Phenotype and I g Gene Rearrangements of Hodgkin's Disease Derived Cell Line ZO Indicating a B-Cell Origin.- Characterization of Hodgkin's Disease Derived Cell Line HDLM-2.- A New Hypothesis on the Cellular Origin of Reed-Sternberg and Hodgkin Cells Based on the Immunological and Molecular Genetic Analysis of the KM-H2 Line.- A Marker and Putative Pathoantigen of Hodgkin's Cells.- Development in Diagnostic Procedures.- Radiolabeled Monoclonal Antibodies Against Reed-Sternberg Cells for in Vivo Imaging of Hodgkin's Disease by Immunoscintigraphy.- Diagnostic Strategies and Staging Procedures for Hodgkin's Lymphoma: Bone Marrow Scintigraphy and Magnetic Resonance Imaging.- Therapeutic Strategies.- Overviews.- Radiotherapy Trials in Hodgkin's Disease.- Current Status of Chemotherapy for Hodgkin's Disease.- Report on Recent and Current Clinical Trials.- Risk Factor Adapted Treatment of Hodgkin's Lymphoma: Strategies and Perspectives.- Reduced Combined Radiotherapy and Chemotherapy for Hodgkin's Disease - Risk-Adapted Treatment Approach.- Hodgkin's Disease: The Milan Cancer Institute Experience with MOPP and ABVD.- EORTC Lymphoma Cooperative Group Studies in Clinical Stage I-II Hodgkin's Disease - 1963 1987.- Current Stanford Clinical Trials for Hodgkin's Disease.- Results and Prognostic Factors Following Optimal Treatment in Advanced Hodgkin's Disease.- Two Cycles of MOPP and Definitive Radiotherapy for Stage IIIA and III B Hodgkin's Disease.- Risk Factor Adapted Treatment of Hodgkin's Lymphoma in Childhood: Strategies and Results of Three Consecutive Multicenter Studies in the Federal Republic of Germany.- Hodgkin's Disease in Children: Adaptation of Treatment to Risk Factors.- Role of Bone Marrow Transplantation in the Treatment of Hodgkin's Lymphoma.- Conventional Salvage Therapy for Hodgkin's Lymphoma.- High-Dose Combination Chemotherapy with Cyclophosphamide, Carmustine, Etoposide, and Autologous Bone Marrow Transplantation in 60 Patients with Relapsed Hodgkin's Disease: The M. D. Anderson Experience.- Treatment of Resistant Hodgkin's Lymphoma with Bone Marrow Transplantation in Italy.- Preliminary Results of Autologous Bone Marrow Transplantation in the Management of Resistant Hodgkin's Disease: Experience of the Bloomsbury Transplant Group at University College, London.- Bone Marrow Transplantation in the Treatment of Hodgkin's Lymphoma: Problems, Remaining Challenges, and Future Prospects.- Acute and Late Side Effects of Treatment.- Quality of Life During and After Treatment of Hodgkin's Disease.- Risk of Secondary Acute Leukemia and Preleukemia After Hodgkin's Disease: The Institut Gustave-Roussy Experience.